The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

Live updates and the latest news as the Senate turns to a government funding bill to avoid a shutdown and Trump's pick to ...

As the director of the National Security Archive’s Climate Change Transparency Project, Rachel Santarsiero is in the business of monitoring and facilitating the flow of information from the government ...

As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...

Florida, New Hampshire, North Carolina, Texas, Virginia and even Arizona’s Democratic governor are pursuing statewide plans to help find immigrants for possible deportation.

Kübler-Ross’s career was marked by an unwavering commitment to treating dying patients with dignity and respect at a time when the medical community largely avoided discussions about death.

The U.S. Food and Drug Administration told staff this week it cannot guarantee work space or parking spots among the hurdles ...

The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...

Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.

President Donald Trump's nominee to lead the Food and Drug Administration (FDA) Dr. Marty Makary passed a key committee vote on Thursday morning.

The Senate Committee on Health, Labor and Pensions voted Thursday to approve Marty Makary as commissioner of the Food and Drug Administration. He will likely be confirmed in the full Senate.